SORL1 rare variants: A major risk factor for familial early-onset Alzheimer's disease

Molecular Psychiatry

Volumn 21, Issue 6, 2016, Pages 831-836

  Nicolas, G ^a,b   Charbonnier, C ^a,b   Wallon, D ^a,b   Quenez, O ^a,b   Bellenguez, C ^c,d,e   Grenier Boley, B ^c,d,e   Rousseau, S ^a   Richard, A C ^a   Rovelet Lecrux, A ^b   Le Guennec, K ^b   Bacq, D ^f   Garnier, J G ^f   Olaso, R ^f   Boland, A ^f   Meyer, V ^f   Deleuze, J F ^f,g   Amouyel, P ^c,d,e   Munter, H M ^h   Bourque, G ^h   Lathrop, M ^h   Frebourg, T ^a,b   Redon, R ^i,j   Letenneur, L ^k   Dartigues, J F ^k   Genin E ^l   Lambert, J C ^c,d,e   Hannequin, D ^a,b   Campion, D ^a,b,m   more..

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY OF ROUEN   (France)

^c INSERM   (France)

^d INSTITUT PASTEUR DE LILLE   (France)

^e UNIV LILLE   (France)

^f DIF   (France)

^g Ctr d'Etud du Polymorphisme Humain 27 Rue Juliette Dodu 75010   (France)

^h MCGILL UNIVERSITY   (Canada)

ⁱ NANTES UNIVERSITY HOSPITAL   (France)

^j UNIVERSITÉ DE NANTES   (France)

^k UNIVERSITÉ DE BORDEAUX   (France)

^l UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

^m Rouvray Psychiatric Hospital   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

RECEPTOR; SORTILIN RELATED RECEPTOR 1; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APP PROTEIN, HUMAN; CARRIER PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; SORL1 PROTEIN, HUMAN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; EARLY ONSET ALZHEIMER DISEASE; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; RISK FACTOR; VERY ELDERLY; YOUNG ADULT; ALLELE; EXOME; FRANCE; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; METABOLISM; ODDS RATIO;

ALLELES; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; CASE-CONTROL STUDIES; EXOME; FEMALE; FRANCE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; LDL-RECEPTOR RELATED PROTEINS; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; ODDS RATIO; RISK FACTORS;

EID: 84940054847     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2015.121     Document Type: Article

References (23)

1. Rogaeva E, Meng Y, Lee JH, Gu Y, Kawarai T, Zou F, et al. The neuronal sortilinrelated receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet 2007; 39: 168-177
2. Dodson SE, Andersen OM, Karmali V, Fritz JJ, Cheng D, Peng J, et al. Loss of LR11/SORLA enhances early pathology in a mouse model of amyloidosis: evidence for a proximal role in Alzheimer's disease. J Neurosci 2008; 28: 12877-12886
3. Andersen OM, Reiche J, Schmidt V, Gotthardt M, Spoelgen R, Behlke J, et al. Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. Proc Natl Acad Sci USA 2005; 102: 13461-13466
4. Caglayan S, Takagi-Niidome S, Liao F, Carlo AS, Schmidt V, Burgert T, et al. Lysosomal sorting of amyloid-beta by the SORLA receptor is impaired by a familial Alzheimer's disease mutation. Sci Transl Med 2014; 6: 223ra20
5. Pottier C, Hannequin D, Coutant S, Rovelet-Lecrux A, Wallon D, Rousseau S, et al. High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease. Mol Psychiatry 2012; 17: 875-879
6. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7: 263-269
7. Duits FH, Prins ND, Lemstra AW, Pijnenburg YA, Bouwman FH, Teunissen CE, et al. Diagnostic impact of CSF biomarkers for Alzheimer's disease in a tertiary memory clinic. Alzheimers Dement 2014; 11: 523-532
8. Rovelet-Lecrux A, Hannequin D, Raux G, Le Meur N, Laquerriere A, Vital A, et al. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet 2006; 38: 24-26
9. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011; 72: 245-256
10. Beck J, Pittman A, Adamson G, Campbell T, Kenny J, Houlden H, et al. Validation of next-generation sequencing technologies in genetic diagnosis of dementia. Neurobiol Aging 2014; 35: 261-265
11. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 2010; 20: 1297-1303
12. Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 2010; 26: 589-595
13. Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-Throughput sequencing data. Nucleic Acids res 2010; 38: e164
14. Anderson CA, Pettersson FH, Clarke GM, Cardon LR, Morris AP, Zondervan KT. Data quality control in genetic case-control association studies. Nat Protoc 2010; 5: 1564-1573
15. Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 2015; 4: 7
16. Wang GT, Peng B, Leal SM. Variant association tools for quality control and analysis of large-scale sequence and genotyping array data. Am J Hum Genet 2014; 94: 770-783
17. Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, et al. Meta-Analysis of 74, 046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet 2013; 45: 1452-1458
18. Young JE, Boulanger-Weill J, Williams DA, Woodruff G, Buen F, Revilla AC, et al. Elucidating molecular phenotypes caused by the SORL1 Alzheimer's disease genetic risk factor using human induced pluripotent stem cells. Cell Stem Cell 2015; 16: 373-385
19. Vardarajan BN, Zhang Y, Lee JH, Cheng R, Bohm C, Ghani M, et al. Coding mutations in SORL1 and Alzheimer disease. Ann Neurol 2015; 77: 215-227
20. Babron MC, de Tayrac M, Rutledge DN, Zeggini E, Genin E. Rare and low frequency variant stratification in the UK population: description and impact on association tests. PLoS One 2012; 7: e46519
21. Do R, Stitziel NO, Won HH, Jorgensen AB, Duga S, Angelica Merlini P, et al. Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction. Nature 2015; 518: 102-106
22. Liu L, Sabo A, Neale BM, Nagaswamy U, Stevens C, Lim E, et al. Analysis of rare, exonic variation amongst subjects with autism spectrum disorders and population controls. PLoS Genet 2013; 9: e1003443
23. Purcell SM, Moran JL, Fromer M, Ruderfer D, Solovieff N, Roussos P, et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 2014; 506: 185-190